FIELD: medicine.
SUBSTANCE: invention concerns medicine area, namely to treatment and cancer prevention. Application of nonradioactive strontium with an amino acid and an inorganic element for manufacturing of the pharmaceutical agent for treatment or prevention of cancer of prostate, carcinoma of kidneys or melanoma is offered. Application of nonradioactive strontium allows reducing cost of treatment and improving treatment acceptability by patients at the expense of absence of by-effects at application of the offered pharmaceutical agent. Also, application of the offered pharmaceutical agent allows reaching a nontoxic way of treatment and cancer prevention.
EFFECT: reduction of cost of treatment and improvement of treatment acceptability by patients at the expense of absence of by-effects at application of the offered pharmaceutical agent, and also achievement of a nontoxic way of treatment and cancer prevention.
8 cl, 3 ex, 4 tbl
